Display Title IMS June 2018 Weight 0 Tags TX-001 Presentations & Posters - IMS June 2018 Content Progesterone bioavailability for preventing endometrial stimulation with a continuous-combined regimen of TX-001HR (oral estradiol and micronized progesterone capsules) 1 MB Effects of TX-001HR on Uterine Bleeding Rates in Menopausal Women with Vasomotor Symptoms 1 MB 17β-Estradiol/Progesterone in a Single Oral Softgel Capsule (TX-001HR) Significantly Reduced Moderate-to-Severe Vasomotor Symptoms without Endometrial Hyperplasia 92.7 KB TX-001HR is Associated with a Clinically Meaningful Effect on Vasomotor Symptoms 277.5 KB Categories Publications
